MEDICAPS Financial Statements

MEDICAPS Quarterly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2019 Mar-2018
Growth matrix (%)        
Revenue growth 33.40 (17) 4.24 12.80
Op profit growth (258) (249) 122 36.70
EBIT growth (293) (206) 308 (22)
Net profit growth (290) (209) 369 (16)
Profitability ratios (%)        
OPM 18.90 (16) 8.90 4.18
EBIT margin 19.60 (14) 10.70 2.73
Net profit margin 19.40 (14) 10.40 2.31
RoCE 11.40 (6.20) 5.91 1.50
RoNW 2.84 (1.60) 1.45 0.32
RoA 2.83 (1.60) 1.44 0.32
Per share ratios ()        
EPS 8.92 (4.70) 4.32 0.92
Dividend per share -- -- -- --
Cash EPS 7.70 (6.20) 2.86 (0.50)
Book value per share 84 72.90 76.70 72.30
Valuation ratios        
P/E 4.52 (1.70) 3.83 25.10
P/CEPS 5.24 (1.30) 5.79 (45)
P/B 0.48 0.11 0.22 0.32
EV/EBIDTA 3.41 (2.30) 2.49 8.45
Payout (%)        
Dividend payout -- -- -- --
Tax payout 0.05 0.14 (2.10) (15)
Liquidity ratios        
Debtor days 34.30 73.20 91.20 80.70
Inventory days 38.70 69.50 74.40 85.90
Creditor days (32) (31) (49) (41)
Leverage ratios        
Interest coverage -- 346 (307) (204)
Net debt / equity (0.10) -- -- --
Net debt / op. profit (0.60) 0.17 (0.50) (1)
Cost breakup ()        
Material costs (51) (62) (51) (54)
Employee costs (12) (26) (18) (18)
Other costs (18) (28) (22) (24)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Revenue 57.40 43.10 51.80 49.70
yoy growth (%) 33.40 (17) 4.24 12.80
Raw materials (29) (27) (26) (27)
As % of sales 51.10 62.30 50.90 54.40
Employee costs (6.70) (11) (9.60) (8.80)
As % of sales 11.70 25.60 18.50 17.60
Other costs (10) (12) (11) (12)
As % of sales 18.20 28 21.80 23.80
Operating profit 10.90 (6.90) 4.61 2.07
OPM 18.90 (16) 8.90 4.18
Depreciation (1.50) (1.80) (1.80) (1.80)
Interest expense -- -- -- --
Other income 1.89 2.87 2.73 1.07
Profit before tax 11.20 (5.80) 5.50 1.35
Taxes 0.01 -- (0.10) (0.20)
Tax rate 0.05 0.14 (2.10) (15)
Minorities and other (0.10) -- -- --
Adj. profit 11.10 (5.90) 5.39 1.15
Exceptional items -- -- -- --
Net profit 11.10 (5.90) 5.39 1.15
yoy growth (%) (290) (209) 369 (16)
NPM 19.40 (14) 10.40 2.31
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Profit before tax 11.20 (5.80) 5.50 1.35
Depreciation (1.50) (1.80) (1.80) (1.80)
Tax paid 0.01 -- (0.10) (0.20)
Working capital (7) (4.10) (4) (0.50)
Other operating items -- -- -- --
Operating cashflow 2.74 (12) (0.50) (1.20)
Capital expenditure 71.50 32.40 31.60 31.20
Free cash flow 74.30 20.70 31.20 30
Equity raised 176 179 153 148
Investments (1.60) (15) (12) (23)
Debt financing/disposal -- (0.30) 6.39 9.04
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 248 185 179 164
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 12.50 12.50 12.50 12.50
Preference capital -- -- -- --
Reserves 92.20 78.50 83.10 77.80
Net worth 105 91 95.60 90.20
Minority interest
Debt -- 0.06 0.12 0.17
Deferred tax liabilities (net) 0.43 0.43 0.42 0.41
Total liabilities 105 91.40 96.10 90.80
Fixed assets 58.70 58.30 59.80 61
Intangible assets
Investments 29.40 22 16.40 11.20
Deferred tax asset (net) -- -- -- --
Net working capital 10.30 9.98 17.50 16.30
Inventories 6.71 5.45 10.90 10.20
Inventory Days 42.70 46.20 77.10 74.70
Sundry debtors 6.39 4.41 12.90 13
Debtor days 40.60 37.40 90.60 95.70
Other current assets 6.84 3.88 4.20 3.18
Sundry creditors (6.20) (2) (6.40) (6.20)
Creditor days 39.20 16.50 45.40 45.80
Other current liabilities (3.50) (1.80) (4) (3.90)
Cash 6.81 1.25 2.48 2.32
Total assets 105 91.50 96.20 90.80
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Dec-2021 Sep-2021 Jun-2021 Mar-2021 Dec-2020
Gross Sales 17.80 17.30 17.20 13.10 18.20
Excise Duty -- -- -- -- --
Net Sales 17.80 17.30 17.20 13.10 18.20
Other Operating Income -- -- 0.04 0.43 --
Other Income 0.21 0.13 0.19 0.45 0.11
Total Income 18 17.40 17.40 14 18.30
Total Expenditure ** 15.50 13.80 13.60 11 14.60
PBIDT 2.52 3.66 3.82 3 3.71
Interest -- -- -- -- --
PBDT 2.52 3.66 3.82 3 3.71
Depreciation 0.47 0.47 0.47 0.40 0.37
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- --
Deferred Tax -- -- -- -- --
Reported Profit After Tax 2.05 3.19 3.35 2.61 3.34
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 2.05 3.19 3.35 2.61 3.34
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 2.05 3.19 3.35 2.61 3.34
EPS (Unit Curr.) 1.64 2.59 3.20 2.42 3.45
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 12.50 12.50 12.50 12.50 12.50
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 14.20 21.10 22.20 22.90 20.40
PBDTM(%) 14.20 21.10 22.20 22.90 20.40
PATM(%) 11.50 18.40 19.50 19.90 18.40
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity